Stereotaxis to Acquire Robocath

April 15, 2026–Stereotaxis, a St. Louis, Missouri–based company focused on robotics for endovascular intervention, announced that it has entered into a definitive agreement to acquire Robocath. Headquartered in Rouen, France, Robocath develops robotic technologies for interventional cardiology and neurointervention.

The acquisition is subject to customary closing conditions and is expected to close in mid-2026; upon closing, Robocath will operate as a wholly owned subsidiary of Stereotaxis, advised the press release.

According to Stereotaxis, the acquisition combines complementary technologies for next-generation, fully integrated robotic solutions for electrophysiology, interventional cardiology, and neurointervention. The Stereotaxis magnetic navigation technology with Robocath’s mechanical robotic system creates a highly differentiated, fully robotic solution for endovascular surgery.

Robocath’s flagship R-One+ system is a commercially available robotic solution that is currently available for percutaneous coronary interventions in Europe. Additionally, Robocath is developing a next-generation system that is designed to enable simultaneous manipulation of up to five interventional devices. Initial first-in-human procedures were recently successfully completed in France.

Stereotaxis advised that it plans to accelerate the development of Robocath’s next-generation system and pursue regulatory submissions in the United States and Europe within the next 2 years.

Stereotaxis will enhance Robocath’s system with existing proprietary hardware and software embedded within GenesisX, Synchrony (which recently received FDA clearance), and SynX to enable advanced functionality, including operating room integration, automation, and remote procedures.

The company stated that the transaction includes an upfront payment of $20 million with additional contingent payments of up to $25 million tied to regulatory and commercial milestones, including FDA clearance of Robocath’s next-generation system.